These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 35988295)

  • 41. A Computational Study on the Interaction of NSP10 and NSP14: Unraveling the RNA Synthesis Proofreading Mechanism in SARS-CoV-2, SARS-CoV, and MERS-CoV.
    Sarma H; Sastry GN
    ACS Omega; 2022 Aug; 7(34):30003-30022. PubMed ID: 36035077
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Molecular Docking Studies to Identify Promising Natural Inhibitors Targeting SARS-CoV-2 Nsp10-Nsp16 Protein Complex.
    Bhardwaj A; Sharma S; Singh SK
    Turk J Pharm Sci; 2022 Feb; 19(1):93-100. PubMed ID: 35227055
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Exploring the Catalytic Mechanism of the RNA Cap Modification by nsp16-nsp10 Complex of SARS-CoV-2 through a QM/MM Approach.
    Silva JRA; Urban J; Araújo E; Lameira J; Moliner V; Alves CN
    Int J Mol Sci; 2021 Dec; 23(1):. PubMed ID: 35008724
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Identifying SARS-CoV-2 antiviral compounds by screening for small molecule inhibitors of Nsp14 RNA cap methyltransferase.
    Basu S; Mak T; Ulferts R; Wu M; Deegan T; Fujisawa R; Tan KW; Lim CT; Basier C; Canal B; Curran JF; Drury LS; McClure AW; Roberts EL; Weissmann F; Zeisner TU; Beale R; Cowling VH; Howell M; Labib K; Diffley JFX
    Biochem J; 2021 Jul; 478(13):2481-2497. PubMed ID: 34198328
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Computational Investigation of Structural Dynamics of SARS-CoV-2 Methyltransferase-Stimulatory Factor Heterodimer nsp16/nsp10 Bound to the Cofactor SAM.
    Sk MF; Jonniya NA; Roy R; Poddar S; Kar P
    Front Mol Biosci; 2020; 7():590165. PubMed ID: 33330626
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Structure-Based Virtual Screening Identifies Multiple Stable Binding Sites at the RecA Domains of SARS-CoV-2 Helicase Enzyme.
    Ahmad S; Waheed Y; Ismail S; Bhatti S; Abbasi SW; Muhammad K
    Molecules; 2021 Mar; 26(5):. PubMed ID: 33800013
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Structural analysis, virtual screening and molecular simulation to identify potential inhibitors targeting 2'-O-ribose methyltransferase of SARS-CoV-2 coronavirus.
    Jiang Y; Liu L; Manning M; Bonahoom M; Lotvola A; Yang Z; Yang ZQ
    J Biomol Struct Dyn; 2022 Feb; 40(3):1331-1346. PubMed ID: 33016237
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Localization of SARS-CoV-2 Capping Enzymes Revealed by an Antibody against the nsp10 Subunit.
    Horova V; Landova B; Hodek J; Chalupsky K; Krafcikova P; Chalupska D; Duchoslav V; Weber J; Boura E; Klima M
    Viruses; 2021 Jul; 13(8):. PubMed ID: 34452352
    [TBL] [Abstract][Full Text] [Related]  

  • 49. In Silico Screening of Natural Products as Potential Inhibitors of SARS-CoV-2 Using Molecular Docking Simulation.
    Hossain R; Sarkar C; Hassan SMH; Khan RA; Arman M; Ray P; Islam MT; Daştan SD; Sharifi-Rad J; Almarhoon ZM; Martorell M; Setzer WN; Calina D
    Chin J Integr Med; 2022 Mar; 28(3):249-256. PubMed ID: 34913151
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Identification of fragments binding to SARS-CoV-2 nsp10 reveals ligand-binding sites in conserved interfaces between nsp10 and nsp14/nsp16.
    Kozielski F; Sele C; Talibov VO; Lou J; Dong D; Wang Q; Shi X; Nyblom M; Rogstam A; Krojer T; Fisher Z; Knecht W
    RSC Chem Biol; 2022 Jan; 3(1):44-55. PubMed ID: 35128408
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Mapping major SARS-CoV-2 drug targets and assessment of druggability using computational fragment screening: Identification of an allosteric small-molecule binding site on the Nsp13 helicase.
    Freidel MR; Armen RS
    PLoS One; 2021; 16(2):e0246181. PubMed ID: 33596235
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Short peptides derived from the interaction domain of SARS coronavirus nonstructural protein nsp10 can suppress the 2'-O-methyltransferase activity of nsp10/nsp16 complex.
    Ke M; Chen Y; Wu A; Sun Y; Su C; Wu H; Jin X; Tao J; Wang Y; Ma X; Pan JA; Guo D
    Virus Res; 2012 Aug; 167(2):322-8. PubMed ID: 22659295
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Structure and dynamics of SARS-CoV-2 proofreading exoribonuclease ExoN.
    Moeller NH; Shi K; Demir Ö; Belica C; Banerjee S; Yin L; Durfee C; Amaro RE; Aihara H
    Proc Natl Acad Sci U S A; 2022 Mar; 119(9):. PubMed ID: 35165203
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Finding potent inhibitors against SARS-CoV-2 main protease through virtual screening, ADMET, and molecular dynamics simulation studies.
    Roy R; Sk MF; Jonniya NA; Poddar S; Kar P
    J Biomol Struct Dyn; 2022 Sep; 40(14):6556-6568. PubMed ID: 33682642
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Peptide inhibitors against SARS-CoV-2 2'-O-methyltransferase involved in RNA capping: A computational approach.
    Dutta M; Iype E
    Biochem Biophys Rep; 2021 Sep; 27():101069. PubMed ID: 34250275
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Identification of potential target endoribonuclease NSP15 inhibitors of SARS-COV-2 from natural products through high-throughput virtual screening and molecular dynamics simulation.
    Hu LC; Ding CH; Li HY; Li ZZ; Chen Y; Li LP; Li WZ; Liu WS
    J Food Biochem; 2022 May; 46(5):e14085. PubMed ID: 35128681
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Structural basis and functional analysis of the SARS coronavirus nsp14-nsp10 complex.
    Ma Y; Wu L; Shaw N; Gao Y; Wang J; Sun Y; Lou Z; Yan L; Zhang R; Rao Z
    Proc Natl Acad Sci U S A; 2015 Jul; 112(30):9436-41. PubMed ID: 26159422
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Reconstitution and functional characterization of SARS-CoV-2 proofreading complex.
    Ma Z; Pourfarjam Y; Kim IK
    Protein Expr Purif; 2021 Sep; 185():105894. PubMed ID: 33933612
    [TBL] [Abstract][Full Text] [Related]  

  • 59. In silico analysis and identification of antiviral coumarin derivatives against 3-chymotrypsin-like main protease of the novel coronavirus SARS-CoV-2.
    Abdizadeh R; Hadizadeh F; Abdizadeh T
    Mol Divers; 2022 Apr; 26(2):1053-1076. PubMed ID: 34213728
    [TBL] [Abstract][Full Text] [Related]  

  • 60. SS148 and WZ16 inhibit the activities of nsp10-nsp16 complexes from all seven human pathogenic coronaviruses.
    Li F; Ghiabi P; Hajian T; Klima M; Li ASM; Khalili Yazdi A; Chau I; Loppnau P; Kutera M; Seitova A; Bolotokova A; Hutchinson A; Perveen S; Boura E; Vedadi M
    Biochim Biophys Acta Gen Subj; 2023 Apr; 1867(4):130319. PubMed ID: 36764586
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.